Higher derived time in range with insulin degludec/insulin aspart vs insulin glargine U100 in Japanese adults with T2D

Mapping Intimacies ◽

10.26226/morressier.617c37307c09fc044a975188 ◽

2021 ◽

Author(s):

Athena Philis-Tsimikas ◽

Balamurali Kalyanam ◽

John Michael D'Cruz ◽

Christophe De Block ◽

Ramsathish Sivarathinasami ◽

...

Keyword(s):

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Japanese Adults ◽

Time In Range

Download Full-text

Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin

Primary Care Diabetes ◽

10.1016/j.pcd.2020.08.004 ◽

2021 ◽

Vol 15 (1) ◽

pp. 132-137

Author(s):

Anwar Ali Jammah

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Basal Insulin ◽

Indirect Comparison ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Diabetes Patients

Download Full-text

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet ◽

10.1016/s0140-6736(12)60204-9 ◽

2012 ◽

Vol 379 (9825) ◽

pp. 1489-1497 ◽

Cited By ~ 221

Author(s):

Simon Heller ◽

John Buse ◽

Miles Fisher ◽

Satish Garg ◽

Michel Marre ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Treat To Target ◽

Open Label ◽

Phase 3 ◽

Mealtime Insulin ◽

Basal Bolus

Download Full-text

Insulin aspart/insulin degludec/insulin glargine

Reactions Weekly ◽

10.1007/s40278-020-77532-4 ◽

2020 ◽

Vol 1800 (1) ◽

pp. 170-170

Keyword(s):

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Aspart Insulin

Download Full-text

Effect of Insulin Degludec U100 vs Insulin Glargine U100 on Time in Range in Patients with Type 2 Diabetes at Risk of Hypoglycaemia

10.1055/s-0041-1727342 ◽

2021 ◽

Author(s):

R Goldenberg ◽

VR Aroda ◽

LK Billings ◽

ASL Christiansen ◽

AM Donatsky ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Insulin Glargine ◽

Insulin Degludec ◽

Time In Range

Download Full-text

PDB19 COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

Value in Health ◽

10.1016/j.jval.2020.04.207 ◽

2020 ◽

Vol 23 ◽

pp. S111

Author(s):

C. Liu ◽

L.B. Tao ◽

F. Wang

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Insulin Degludec ◽

Effectiveness Analysis

Download Full-text

Superior glycaemic control with once‐daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12097 ◽

2013 ◽

Vol 15 (9) ◽

pp. 826-832 ◽

Cited By ~ 41

Author(s):

Y. Onishi ◽

Y. Ono ◽

R. Rabøl ◽

L. Endahl ◽

S. Nakamura

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Insulin Degludec ◽

Oral Drugs ◽

Phase 3 ◽

Once Daily ◽

Randomized Controlled ◽

Japanese Adults

Download Full-text

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0163350 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0163350 ◽

Cited By ~ 13

Author(s):

Ajay Kumar ◽

Edward Franek ◽

Jonathan Wise ◽

Marcus Niemeyer ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Insulin Aspart ◽

Controlled Trial ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Once Daily ◽

Randomized Controlled

Download Full-text

A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results from Continuous Glucose Monitoring in a Proof-of-Concept Trial

Journal of Diabetes Science and Technology ◽

10.1177/193229681300700524 ◽

2013 ◽

Vol 7 (5) ◽

pp. 1328-1336 ◽

Cited By ~ 15

Author(s):

Andreas Liebl ◽

Jaime Davidson ◽

Henriette Mersebach ◽

Patrik Dykiel ◽

Cees J. Tack ◽

...

Keyword(s):

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Insulin Aspart ◽

Glucose Monitoring ◽

Insulin Degludec ◽

Proof Of Concept ◽

Glucose Profile

Download Full-text

Insulin-aspart/insulin-degludec/insulin-glargine

Reactions Weekly ◽

10.1007/s40278-017-38158-7 ◽

2017 ◽

Vol 1676 (1) ◽

pp. 170-170

Keyword(s):

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Aspart Insulin

Download Full-text

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN ® Basal–Bolus Type 1): 2‐year results of a randomized clinical trial

Diabetic Medicine ◽

10.1111/dme.12243 ◽

2013 ◽

Vol 30 (11) ◽

pp. 1293-1297 ◽

Cited By ~ 65

Author(s):

B. W. Bode ◽

J. B. Buse ◽

M. Fisher ◽

S. K. Garg ◽

M. Marre ◽

...

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Insulin Aspart ◽

Insulin Degludec ◽

Nocturnal Hypoglycaemia ◽

Mealtime Insulin ◽

Basal Bolus

Download Full-text